Open Research and Contributor Identifier
Karolinska Institutet, Ph.D. in Epidemiology, 2008
Chinese Center for Disease Control and Prevention, M.S. in Biostatistics, 1995
Beijing Normal University, B.S. in Mathematics, 1989
- 07/2021 - Present, Professor Dept. of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, IN
- 07/2015 - 06/2021, Associate Professor with tenure Dept. of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, IN
- January 2013 - June 2015, Assistant Professor, Dept. of Epidemiology and Biostatistics, School of Public Health - Bloomington, Indiana University
- March 2009 - December 2012, Assistant Professor, Dept. of Epidemiology, School of Public Health, West Virginia University with a joint appointment with Mary Babb Randolph Cancer Center
Awards and Honors
- 2017 American Journal of Epidemiology Article of the Year
- 2015 School of Public Health Outstanding Early Career Scholar Award, Indiana Univeristy
- 2014 Delta Omega Initiate to the Gamma Beta Chapter at Indiana University, Delta Omega Honorary Society in Public Health
- R03CA256238-01; Source: NIH/NCI; Title: Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors and lung cancer prognosis; Role: PI; Period: 2021-2023; Amount: $158,500
- 1R15CA179463-01; Sources: NIH/NCI; Title: Diabetes, Metformin and Breast Cancer Prognosis; Role: PI; Period: 9/1/2013-8/31/2016; Amount: $414,602
Dr. Luo's research and training have focused on lifestyle and environmental factors in relation to cancer risk and cancer prognosis, particularly for breast, lung and pancreatic cancer. She has been involved in the Women's Health Initiative, a large prospective cohort since 2005. Her current research interests include: (1) Tobacco use and cancer risk; (2)Diabetes and cancer risk and prognosis; (3)Obesity, weight change and cancer risk; and (4)Environmental pollutants and cancer risk.
(selected from a total of 155 peer-reviewed articles)
Luo J, Dinh P*, Hendryx M, Li W. Robinson J, Margolis KL. Risk patterns and mortality in postmenopausal women using latent class analysis. American Journal of Preventive Medicine. July 05, 2021. DOI: https://doi.org/10.1016/j.amepre.2021.04.025.
Luo J, Kroenke CH, Hendryx M, Shadyab AH, Liu N, Chen X, Wang F*, Thomas F, Nazmus Saquib N, Qi L, Cheng TYD, Arthur R, Wactawski-Wende J. Mediation analysis of racial disparities in triple-negative breast cancer incidence among postmenopausal women. Breast Cancer Research and Treatment. 07 March 2021. doi: 10.1007/s10549-021-06158-y. Online ahead of print.
Luo J, Rohan TE, Neuhouser ML, Liu N, Saquib N, Li Y*, Shadyab AH, Qi L, Wallace RB, Hendryx M. Hysterectomy, oophorectomy and risk of renal cell carcinoma. Cancer Epidemiology, Biomarkers & Prevention. 2020 Dec 17; cebp.1373.2020. doi: 10.1158/1055-9965.EPI-20-1373. Online ahead of print.
Luo J, Hendryx M. Metal Mixtures and Kidney Function: An Application of Machine Learning to NHANES Data. Environmental Research. 2020 Aug 21;191:110126. doi: 10.1016/j.envres.2020.110126. Online ahead of print.
Guo D*, Hendryx M, Liang X, Manson JE, He K, Vitolins MZ, Li Y*, Luo J. Association between selenium intake and breast cancer risk: Results from the Women's Health Initiative. Breast Cancer Research and Treatment. 2020 Jun 30. doi: 10.1007/s10549-020-05764-6. Online ahead of print.
Li Y*, Hendryx M, Xun P, He K, Shadyab AH, Lane DS, Nassir R, Stefanick ML, Wactawski-Wende J, Pal SK, Luo J. Physical activity and risk of bladder cancer among postmenopausal women. Int J Cancer. 2020 May 10. doi: 10.1002/ijc.33042. Online ahead of print.
Luo J, Hodge A, Hendryx M, Byles JE. Age of obesity onset and cumulative obesity exposure over young adulthood and risk of type 2 diabetes. Diabetologia. 2020;63(3):519-527.
Luo J, Chen X, Manson JE, Shadyab AH, Wactawski-Wende J, Vitolins M, Rohan TE, Cheng TYD, Zhang Z, Qi L, Hendryx M. Birth weight, weight over the adult life course, and risk of breast cancer. International Journal of Cancer. 2020;147(1):65-75.
Luo J, Hendryx M, Manson JE, Figueiredo JC, LeBlanc ES, Barrington W, Rohan TE, Howard BV, Reding K, Ho GYF, Garcia DO, Chlebowski RT. Intentional weight loss and obesity-related cancer risk. JNCI Cancer Spectrum. 2019 Aug 9;3(4):pkz054. doi: 10.1093/jncics/pkz054. eCollection 2019 Dec.
Luo J, Hendryx H, Laddu D, Phillips LS, Chlebowski R, LeBlanc ES, Allison DB, Nelson DA, Li Y*, Rosal MS, Stefanick ML, Manson JE. Racial and ethnic differences in anthropometric measures as risk factors for diabetes. Diabetes Care. 2019; 42(1): 126-133.
Luo J, Chlebowski RT, Hendryx M, Rohan T, Wactawski-Wende J, Thomson CA, Felix AS, Chen C, Barrington W, Coday M, Stefanick M, LeBlanc E, Margolis KL. (2017). Intentional weight loss and endometrial cancer risk. Journal of Clinical Oncology, 2017 Feb 6, 2017; JCO2016705822. doi: 10.1200/JCO.2016.70.5822. [Epub ahead of print].
*Liang XY, Margolis KL, Hendryx M, Rohan T, Groessl EJ,! Thomson CA, Kroenke C, Simon M, Lane D, Stefanick M, Luo J. (2017) Metabolic phenotype and risk of colorectal cancer in normal-weight postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention, February 1, 2017; DOI: 10.1158/1055-9965.EPI-16-0761. [Epub ahead of print].
Luo J, Hendryx M, Manson JE, Liang XY, Margolis KL. (2016). Hysterectomy, oophorectomy and risk of thyroid cancer. Journal of Clinical Endocrinology & Metabolism. 101(10),3812-3819.
Luo J, Hendryx M, Qi L, Ho GYF, Margolis KL. (2016). Pre-existing diabetes and lung cancer prognosis. British Journal of Cancer, 115(1),76-79.
Luo J, Hendryx M, Virnig B, Wen S, Chelebowski R, Chen C, Rohan T, Tinker L, Wactawski-Wende J, Lessin L, Margolis KL. (2015). Pre-existing diabetes and breast cancer prognosis among elderly women. British Journal of Cancer, 113 (5), 827-832.
Luo J, Virnig B, Hendryx M, Wen S, Chelebowski R, Chen C, Rohan T, Tinker L, Wactawski-Wende J, Lessin L, Margolis KL. (2014). Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Research and Treatment, 148(1), 153-162.
Luo J, Rossouw J, Margolis KL. (2013). Smoking cessation, weight change and coronary heart disease among postmenopausal women with and without diabetes (research letter). JAMA, 310 (1), 94-96.